Amneal Pharmaceuticals (AMRX) Other Gross PP&E Adjustments (2017 - 2025)
Amneal Pharmaceuticals (AMRX) has 9 years of Other Gross PP&E Adjustments data on record, last reported at $988.4 million in Q4 2025.
- For Q4 2025, Other Gross PP&E Adjustments rose 6.43% year-over-year to $988.4 million; the TTM value through Dec 2025 reached $988.4 million, up 6.43%, while the annual FY2025 figure was $988.4 million, 6.43% up from the prior year.
- Other Gross PP&E Adjustments reached $988.4 million in Q4 2025 per AMRX's latest filing, up from -$16.9 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $988.4 million in Q4 2025 and bottomed at -$179.0 million in Q1 2024.
- Average Other Gross PP&E Adjustments over 5 years is $149.3 million, with a median of -$69.0 million recorded in 2021.
- Peak YoY movement for Other Gross PP&E Adjustments: plummeted 33.98% in 2021, then surged 79.71% in 2025.
- A 5-year view of Other Gross PP&E Adjustments shows it stood at $842.8 million in 2021, then rose by 1.32% to $853.9 million in 2022, then grew by 5.12% to $897.6 million in 2023, then increased by 3.46% to $928.7 million in 2024, then grew by 6.43% to $988.4 million in 2025.
- Per Business Quant database, its latest 3 readings for Other Gross PP&E Adjustments were $988.4 million in Q4 2025, -$16.9 million in Q3 2025, and -$33.2 million in Q2 2025.